Artículos del autor

solaci

Highlights ACC 2016

CoreValve US Pivotal: at 3 Years, the Self-Expanding Valve Maintains Its Advantage vs. Surgery

At 3 year follow up, the CoreValve US Pivotal study on high risk elderly patients, the self-expanding...
solaci -
Highlights ACC 2016

PARTNER 1 in +90 Year Old Patients: TAVI and the Age Paradox

A new analyzis of the PARTNER 1 trial showed that patients over 90 undergoing transcatheter aortic valve...
solaci -
Highlights ACC 2016

DANAMI 3: Deferred Stenting and Ischemic Postconditioning Have No Benefit in Primary PCI

Both ischemic postconditioning and deferred stenting showed no benefit in randomized studies conducted as part of the...
solaci -
Highlights ACC 2016

Morphine Increases Platelet Reactivity in Infarctions

The use of morphine in patients undergoing ST elevation acute coronary syndromes is associated to higher platelet...
solaci -
Highlights ACC 2016

EARLY-BAMI: Metropol Showed No Reduction in Infarct Size.

EARLY-BAMI outcomes show the endovenous administration of metropol before primary PCI does not reduce infarct size. This double...
solaci -
Highlights ACC 2016

New Meta-Analysis Shows Similar Mortality between Bivalirudin and Heparin

This meta-analyzis of contemporary studies comparing the safety and efficacy of bivalirudin vs. heparin showed no differences...
solaci -
Highlights ACC 2016

HOPE 3: Reducing LDL Improves Prognosis in Intermediate Risk Patients

In a large cohort of intermediate risk patients with no known CAD, treatment with low doses of...
solaci -
Highlights ACC 2016

ixCELL-DCM: Stem Cell Therapy Improves Outcomes in Patients with Heart Failure

Enhanced autologous bone marrow stem cell therapy improves clinical cardiac events in patients with heart failure and...
solaci -